Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.224
-0.022 (-9.07%)
Nov 14, 2024, 4:00 PM EST - Market closed
Silexion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2013 | FY 2012 |
| Dec '13 Dec 31, 2013 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
| Net Income | -1.36 | -1.36 | -0.94 |
| Depreciation & Amortization | 0 | 0 | 0 |
| Stock-Based Compensation | 0.42 | 0.42 | 0.04 |
| Change in Accounts Receivable | 0.06 | 0.06 | -0.1 |
| Change in Accounts Payable | 0.02 | 0.02 | 0.06 |
| Change in Other Net Operating Assets | 0.05 | 0.05 | 0.03 |
| Operating Cash Flow | -0.79 | -0.79 | -0.91 |
| Capital Expenditures | -0.01 | -0.01 | -0 |
| Other Investing Activities | -0.01 | -0.01 | -0.03 |
| Investing Cash Flow | -0.02 | -0.02 | -0.03 |
| Issuance of Common Stock | - | - | 1.72 |
| Financing Cash Flow | - | - | 1.72 |
| Net Cash Flow | -0.81 | -0.81 | 0.78 |
| Free Cash Flow | -0.8 | -0.8 | -0.91 |
| Free Cash Flow Per Share | -5.36 | -5.36 | -7.12 |
| Levered Free Cash Flow | -0.31 | -0.31 | - |
| Unlevered Free Cash Flow | -0.3 | -0.3 | - |
| Change in Net Working Capital | -0.12 | -0.12 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.